Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leiomyosarcoma 1

Interventions

Doxorubicin 6 pazopanib 5 Gemcitabine 4 pembrolizumab 3 Trabectedin 3 Sorafenib 3 Docetaxel 3 Dacarbazine 3 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 Nivolumab 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 tremelimumab 1 temsirolimus 1 saracatinib 1 sapanisertib 1 rucaparib 1 romidepsin 1 olaratumab 1 mocetinostat 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 durvalumab 1 cixutumumab 1 cabozantinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Leiomyosarcoma × PTC596 × Clear all

NCT05269355 2025-06-13

SUNRISELMS

PTC Therapeutics

Phase 2/3 Terminated

359 enrolled 15 charts

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡